OKT3 in severe early rejection: predictors for reversal in renal transplant recipients.
作者信息
Sumrani N, Delaney V, Rajpoot D, Tejani A, Butt K, Hong J
机构信息
Department of Surgery, SUNY Health Science Center, Brooklyn 11203.
出版信息
Transplant Proc. 1990 Aug;22(4):1750-2.
PMID:2117797
Abstract
摘要
相似文献
1
OKT3 in severe early rejection: predictors for reversal in renal transplant recipients.
Transplant Proc. 1990 Aug;22(4):1750-2.
2
Reversal of steroid- and antithymocyte globulin-resistant acute rejection crises in renal transplantation with monoclonal antibody (OKT3).
Transplant Proc. 1990 Aug;22(4):1753-4.
3
The effect of induction ALG (MALG) on the outcome of steroid-resistant rejection treated with OKT3 in renal transplant patients.
Transplant Proc. 1991 Feb;23(1 Pt 2):1039-40.
4
5
Immunologic monitoring in OKT3-treated kidney graft recipients.
Transplant Proc. 1990 Aug;22(4):1777-8.
6
Induction immunosuppression with OKT3 monoclonal antibody in cardiac transplant recipients.
Transplant Proc. 1990 Oct;22(5):2319.
7
Use of OKT3 in kidney, pancreas, and liver transplantation.
Transplant Proc. 1990 Aug;22(4):1748-9.
8
Late acute rejection in renal transplant recipients: response to steroid treatment.
Transplant Proc. 1992 Feb;24(1):35-6.
9
Quadruple immunosuppression: comparison of OKT3 and Minnesota antilymphocyte globulin.
Am J Kidney Dis. 1989 Nov;14(5 Suppl 2):10-3.
10
A prospective randomized comparison of prophylactic ALG and OKT3 in cadaver kidney allograft recipients.
Transplant Proc. 1991 Feb;23(1 Pt 2):1050-1.
Zotero 插件